|
|
Volumn 20, Issue 47, 2001, Pages 6955-6959
|
|
The CGA gene as new predictor of the response to endocrine therapy in ERα-positive postmenopausal breast cancer patients
a,b
a
b
b,c
a
c
b
a
|
|
Author keywords
CGA; Endocrine therapy; Postmenopausal breast cancer; Real time RT PCR quantification
|
|
Indexed keywords
ESTROGEN RECEPTOR ALPHA;
GENE PRODUCT;
NEU DIFFERENTIATION FACTOR;
PROTEIN CGA;
TAMOXIFEN;
UNCLASSIFIED DRUG;
ADULT;
AGED;
ALPHA CHAIN;
ARTICLE;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER HORMONE THERAPY;
CANCER RECURRENCE;
CANCER SURGERY;
CANCER SURVIVAL;
DRUG RESPONSE;
ESTROGEN RESPONSIVE ELEMENT;
FEMALE;
GENE OVEREXPRESSION;
HUMAN;
HUMAN TISSUE;
MAJOR CLINICAL STUDY;
ONCOGENE NEU;
POSTMENOPAUSE;
PRIORITY JOURNAL;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
AGED;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CHEMOTHERAPY, ADJUVANT;
COHORT STUDIES;
DISEASE-FREE SURVIVAL;
ESTROGEN ANTAGONISTS;
ESTROGEN RECEPTOR ALPHA;
FEMALE;
GENES;
GLYCOPROTEIN HORMONES, ALPHA SUBUNIT;
HUMANS;
MIDDLE AGED;
POSTMENOPAUSE;
RECEPTOR, ERBB-2;
RECEPTORS, ESTROGEN;
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;
RNA, NEOPLASM;
TAMOXIFEN;
TREATMENT OUTCOME;
TUMOR MARKERS, BIOLOGICAL;
|
|
EID: 0035909525
PISSN: 09509232
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.onc.1204739 Document Type: Article |
|
Times cited : (23)
|
|
References (10)
|
